Dr David Sim
Cardiologist, Heart Failure Program Director, National Heart Center Singapore; Immediate past president of Heart Failure Society (Singapore)
Related Links
- Optimising GDMT Post AHF Discharge – APAC APSC Consensus Highlights
- EMPORIUM – Full Throttle Against HF: From Detection to Protection
- Value of NT-ProBNP for Treatment Monitoring in CHF
- Uncovering the Risk: Heart Failure in Diabetic Patients: Value of the cardiac biomarker NT-proBNP
- Heart Failure in Asia – Present Challenges and Future Strategies
- Dr David Sim’s Clinical Cases: NT-proBNP in Heart Failure Patients
- FAQ: NT-proBNP vs Cardiac Medications
- FAQ: Role of NT-proBNP in Heart Failure Management
